EQS-News: Biohacks (Schweiz) AG
/ Key word(s): Financing
Biohacks AG sets course for planned future growth in the functional foods sector
- Comprehensive corporate realignment
- Additional financial resources through acquisition of a new strategic investor
- Massive strengthening of equity base by a total of CHF 53 million
Lachen/CH, Dusseldorf, 29. April 2022 -Biohacks (Switzerland) AG, an innovative producer and distributor in the fast-growing and promising functional foods sector, is aiming for disproportionate growth by diversifying its product range and entering new markets. In the first four months of the 2022 business year, the company created the financial basis for this by attracting new investors and optimising its balance sheet structure through the integration of the German subsidiary. The equity capital of the company, which is based in Lachen, Switzerland, was increased in two steps by a total of CHF 53 million. First, an international strategic investor subscribed to a capital increase of CHF 3 million in January 2022. In April 2022, the German subsidiary Biohacks GmbH was then contributed into the Biohacks AG, increasing the equity of the Swiss parent company by CHF 50 million. A renowned Swiss auditor confirmed this transaction. At the end of 2020, Biohacks GmbH was valued at a much higher value of over € 100 million by the experts at Kleeberg Valuation, Munich, in an expert opinion on the enterprise value in accordance with IDW S 1. Biohacks has legally completed the transactions in such a way that tax-free dividends of CHF 53 million are available for possible distributions for future new investors.
Based on these measures, Biohacks AG has set its course for financing the next steps of the planned national and international growth. The expansion, which has already begun and is now being accelerated, will initially focus on the nationwide market launch of high-quality vegan products with organic quality under the "SPIRIT" brand and, at a later date, on the expansion of the product range and the introduction of new, innovative health services.
"With the financing steps which have now been completed, we have created an important milestone for the future of Biohacks. They form a very good basis for financing the planned dynamic growth with our high-quality organic vegan products, initially in Germany and then also in other European countries," comments the CEO of the company Dr. Ingo Lange these transactions.
About Biohacks - Upgrade Your Life
For further information, please check: https://biohackscompany.com/
Contact for media inquiries
29.04.2022 Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG.
|Biohacks (Schweiz) AG
|EQS News ID:
|End of News
|EQS News Service